BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 23562907)

  • 1. Bio-generation of stable isotope labeled internal standards for absolute and relative quantitation of drug metabolites in plasma samples by LC-MS/MS.
    Li P; Gong Y; Lim HK; Jian W; Edom RW; Salter R; Silva J; Weng N
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 May; 926():92-100. PubMed ID: 23562907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bio-generation of stable isotope-labeled internal standards for absolute and relative quantitation of phase II drug metabolites in plasma samples using LC-MS/MS.
    Li P; Li Z; Beck WD; Callahan PM; Terry AV; Bar-Peled M; Bartlett MG
    Anal Bioanal Chem; 2015 May; 407(14):4053-63. PubMed ID: 25804729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential bias and mitigations when using stable isotope labeled parent drug as internal standard for LC-MS/MS quantitation of metabolites.
    Jian W; Edom RW; Xu Y; Gallagher J; Weng N
    J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Dec; 878(31):3267-76. PubMed ID: 21056016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitation of parent drug and its unstable metabolites by in situ coulometric oxidation and liquid chromatography-tandem mass spectrometry.
    Tong W; Chowdhury SK; Su AD; Alton KB
    Anal Chem; 2010 Dec; 82(24):10251-7. PubMed ID: 21105697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A simple liquid chromatography-tandem mass spectrometry method to determine relative plasma exposures of drug metabolites across species for metabolite safety assessments (metabolites in safety testing). II. Application to unstable metabolites.
    Gao H; Obach RS
    Drug Metab Dispos; 2012 Jul; 40(7):1290-6. PubMed ID: 22456937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ¹³C labelled internal standards--a solution to minimize ion suppression effects in liquid chromatography-tandem mass spectrometry analyses of drugs in biological samples?
    Berg T; Strand DH
    J Chromatogr A; 2011 Dec; 1218(52):9366-74. PubMed ID: 22119139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A strategy for liquid chromatography/tandem mass spectrometry based quantitation of pegylated protein drugs in plasma using plasma protein precipitation with water-miscible organic solvents and subsequent trypsin digestion to generate surrogate peptides for detection.
    Wu ST; Ouyang Z; Olah TV; Jemal M
    Rapid Commun Mass Spectrom; 2011 Jan; 25(2):281-90. PubMed ID: 21192023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Obtaining exposures of metabolites in preclinical species through plasma pooling and quantitative NMR: addressing metabolites in safety testing (MIST) guidance without using radiolabeled compounds and chemically synthesized metabolite standards.
    Vishwanathan K; Babalola K; Wang J; Espina R; Yu L; Adedoyin A; Talaat R; Mutlib A; Scatina J
    Chem Res Toxicol; 2009 Feb; 22(2):311-22. PubMed ID: 19067650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A simple liquid chromatography-tandem mass spectrometry method to determine relative plasma exposures of drug metabolites across species for metabolite safety assessments.
    Gao H; Deng S; Obach RS
    Drug Metab Dispos; 2010 Dec; 38(12):2147-56. PubMed ID: 20847138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of high-resolution mass spectrometry to investigate a metabolite interference during liquid chromatography/tandem mass spectrometric quantification of a small molecule in toxicokinetic study samples.
    Furlong M; Bessire A; Song W; Huntington C; Groeber E
    Rapid Commun Mass Spectrom; 2010 Jul; 24(13):1902-10. PubMed ID: 20533320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-resolution isotope-dilution mass spectrometry using metabolism of isotope-labeled compounds: application to drug metabolites.
    Vrbanac JJ; Hilgers A; Dubnicka T; Shilliday FB; Humphries D; Hayes RN
    Rapid Commun Mass Spectrom; 2012 Nov; 26(22):2569-76. PubMed ID: 23059872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fractional mass filtering as a means to assess circulating metabolites in early human clinical studies.
    Tiller PR; Yu S; Bateman KP; Castro-Perez J; McIntosh IS; Kuo Y; Baillie TA
    Rapid Commun Mass Spectrom; 2008 Nov; 22(22):3510-6. PubMed ID: 18853407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of exposure multiples of human metabolites for MIST assessment in preclinical safety species without using reference standards or radiolabeled compounds.
    Ma S; Li Z; Lee KJ; Chowdhury SK
    Chem Res Toxicol; 2010 Dec; 23(12):1871-3. PubMed ID: 21121646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of a high-throughput online solid phase extraction-tandem mass spectrometry system for in vivo bioanalytical studies.
    Jian W; Romm MV; Edom RW; Miller VP; LaMarr WA; Weng N
    Anal Chem; 2011 Nov; 83(21):8259-66. PubMed ID: 21936562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid screening for 67 drugs and metabolites in serum or plasma by accurate-mass LC-TOF-MS.
    Marin SJ; Hughes JM; Lawlor BG; Clark CJ; McMillin GA
    J Anal Toxicol; 2012 Sep; 36(7):477-86. PubMed ID: 22802572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A strategy for a post-method-validation use of incurred biological samples for establishing the acceptability of a liquid chromatography/tandem mass-spectrometric method for quantitation of drugs in biological samples.
    Jemal M; Ouyang Z; Powell ML
    Rapid Commun Mass Spectrom; 2002; 16(16):1538-47. PubMed ID: 12203245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of relative 12C/14C isotope ratios to estimate metabolite concentrations in the absence of authentic standards.
    Cuyckens F; Pauwels N; Koppen V; Leclercq L
    Bioanalysis; 2012 Jan; 4(2):143-56. PubMed ID: 22250797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-specific, quantitative methods for analysis of sphingolipids by liquid chromatography-tandem mass spectrometry: "inside-out" sphingolipidomics.
    Sullards MC; Allegood JC; Kelly S; Wang E; Haynes CA; Park H; Chen Y; Merrill AH
    Methods Enzymol; 2007; 432():83-115. PubMed ID: 17954214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of absolute and relative response for three different liquid chromatography/tandem mass spectrometry systems; the impact of ionization and detection saturation.
    Nilsson LB; Skansen P
    Rapid Commun Mass Spectrom; 2012 Jun; 26(12):1399-406. PubMed ID: 22592983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and Use of Stable-Isotope-Labeled Internal Standards for Quantification of Phosphorylated Metabolites by LC-MS/MS.
    Arrivault S; Guenther M; Fry SC; Fuenfgeld MM; Veyel D; Mettler-Altmann T; Stitt M; Lunn JE
    Anal Chem; 2015 Jul; 87(13):6896-904. PubMed ID: 26010726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.